首页> 美国卫生研究院文献>BMC Research Notes >Expression of Hypoxia-Inducible Factor (HIF)-1a-Vascular Endothelial Growth Factor (VEGF)-Inhibitory Growth Factor (ING)-4- axis in sarcoidosis patients

【2h】

Expression of Hypoxia-Inducible Factor (HIF)-1a-Vascular Endothelial Growth Factor (VEGF)-Inhibitory Growth Factor (ING)-4- axis in sarcoidosis patients

机译：结节病患者缺氧诱导因子（HIF）-1a-血管内皮生长因子（VEGF）-抑制性生长因子（ING）-4-轴的表达

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundSarcoidosis is a granulomatous disorder of unknown etiology. The term of immunoangiostasis has been addressed by various studies as potentially involved in the disease pathogenesis. The aim of the study was to investigate the expression of the master regulator of angiogenesis hypoxia inducible factor (HIF)-1a – vascular endothelial growth factor (VEGF)- inhibitor of growth factor 4-(ING4) - axis within sarcoid granuloma.

机译：背景类肉瘤是一种病因不明的肉芽肿性疾病。免疫血管扩张这一术语已被各种研究视为可能与疾病发病机理有关。本研究的目的是研究结节性肉芽肿中血管生成缺氧诱导因子（HIF）-1a –血管内皮生长因子（VEGF）-生长因子4-（ING4）-轴的调控因子的表达。

著录项

期刊名称 BMC Research Notes
作者
Argyris Tzouvelekis; Paschalis Ntolios; Andreas Karameris; Anastasios Koutsopoulos; Panagiotis Boglou; Andreas Koulelidis; Kostas Archontogeorgis; George Zacharis; Fotis Drakopanagiotakis; Paschalis Steiropoulos; Stavros Anevlavis; Vlassis Polychronopoulos; Dimitrios Mikroulis; Demosthenes Bouros;
展开▼
作者单位

展开▼
年(卷),期 2012(5),-1
年度 2012
页码 654
总页数 9
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Expression of Hypoxia-Inducible Factor (HIF)-1a-Vascular Endothelial Growth Factor (VEGF)-Inhibitory Growth Factor (ING)-4- axis in sarcoidosis patients [J] . Argyris Tzouvelekis, Paschalis Ntolios, Andreas Karameris, BMC research notes . 2012,第1期

机译：结节病患者缺氧诱导因子（HIF）-1a-血管内皮生长因子（VEGF）-抑制性生长因子（ING）-4-轴的表达
2. Anti-angiogenic effects of SN38 (active metabolite of irinotecan): inhibition of hypoxia-inducible factor 1 alpha (HIF-1alpha)/vascular endothelial growth factor (VEGF) expression of glioma and growth of endothelial cells. [J] . Kamiyama H, Takano S, Tsuboi K, Journal of Cancer Research and Clinical Oncology . 2005,第4期

机译：SN38（伊立替康的活性代谢产物）的抗血管生成作用：抑制神经胶质瘤的缺氧诱导因子1α（HIF-1α）/血管内皮生长因子（VEGF）表达和内皮细胞生长。
3. Anti-angiogenic effects of SN38 (active metabolite of irinotecan): inhibition of hypoxia-inducible factor 1 alpha (HIF-1α)/vascular endothelial growth factor (VEGF) expression of glioma and growth of endothelial cells [J] . Hiroshi Kamiyama, Shingo Takano, Koji Tsuboi, Journal of Cancer Research and Clinical Oncology . 2005,第4期

机译：SN38（伊立替康的活性代谢产物）的抗血管生成作用：抑制神经胶质瘤的缺氧诱导因子1α（HIF-1α）/血管内皮生长因子（VEGF）表达和内皮细胞生长
4. Leukemia Inhibitory Factor (LIF) and Vascular Endothelial Growth Factor (VEGF) diminish intensity of apoptosis in hypoxic human trophoblast: first- trimester versus term trophoblast cultures. [C] . DARIUSZ SZUKIEWICZ, MICHAL PYZLAK, ALEKSANDRA STANGRET, Recent advances in clinical medicine . 2010

机译：白血病抑制因子（LIF）和血管内皮生长因子（VEGF）降低了缺氧人滋养细胞的凋亡强度：早孕期与足月滋养层培养相比。
5. Strategies in anti-angiogenic cancer therapy: Exploiting the role of vascular endothelial growth factor (VEGF) in tumor growth and endothelial cell survival. [D] . Wild, Robert Christian. 2000

机译：抗血管生成癌治疗的策略：利用血管内皮生长因子（VEGF）在肿瘤生长和内皮细胞存活中的作用。
6. Hypoxia-Inducible Factor 1-Α (HIF1α) and Vascular Endothelial Growth Factor-A (VEGF-A) Expression in De Novo AML Patients [O] . Mohammad Jabari, Mehdi Allahbakhshian Farsani, Sina Salari, 2019

机译：De Novo AML患者缺氧诱导因子1-Α（HIF1α）和血管内皮生长因子-A（VEGF-A）的表达
7. Expression of Hypoxia-Inducible Factor (HIF)-1a-Vascular Endothelial Growth Factor (VEGF)-Inhibitory Growth Factor (ING)-4- axis in sarcoidosis patients [O] . Tzouvelekis Argyris, Ntolios Paschalis, Karameris Andreas, 2012

机译：结节病患者缺氧诱导因子（HIF）-1a-血管内皮生长因子（VEGF）-抑制性生长因子（ING）-4-轴的表达

Expression of Hypoxia-Inducible Factor (HIF)-1a-Vascular Endothelial Growth Factor (VEGF)-Inhibitory Growth Factor (ING)-4- axis in sarcoidosis patients

摘要

著录项

相似文献

相关主题

期刊订阅